Royalty Pharma (RPRX)Director sold ~$1.21M
Gregory Norden, Director at Royalty Pharma, sold ~$1.21M of Royalty Pharma shares.
- ~$1.21M
- Approx. value · 34K sh @ $36.23
- 195K
- Holds after · shares reported
- Traded
- Aug 11, 2025
- Filed
- Aug 11, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 11, 2025 · this disclosureInsiderDirector sold ~$1.21M of RPRX shares in the open market
What came next
- Sep 16, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 17, 2025Insider · 1 personInsiders: 2 sales (~$2.7M)
- Nov 19, 2025Insider · 1 personInsiders: 8 sales (~$5.2M)
- Nov 24, 2025Insider · 1 personInsiders: 4 sales (~$2.7M)
- Dec 1, 2025Insider · 2 peopleInsiders: 4 sales (~$4.4M)
- Dec 3, 2025InsiderOfficer sold ~$4.38M of RPRX shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Royalty Pharma
For Royalty Pharma, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 7 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RPRX page.
Other recent filings by Gregory Norden, Director
The full history of Gregory Norden, Director is on the profile page.
How this filing works
Other disclosures at Royalty Pharma
- SEC Form 4Oct 6, 2026
- SEC Form 144Oct 5, 2026
- SEC Form 4Oct 1, 2026
- SEC Form 4Sep 25, 2026
- SEC Form 4Sep 25, 2026
- SEC Form 4Aug 20, 2026
Everything OQRO holds on this company is on its RPRX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data